Overall, our results demonstrate that the inhibition of FFAR2 signaling exacerbates Aβ-induced neurotoxicity, while its activation by Fenchol reverses these abnormalities, and suggests that potential FFAR2 activators like Fenchol can prevent AD progression (Figure 7). Here, FFAR2 is linked to Alzheimer disease.